TerminatedNCT04181957
Effects of LDX on Cognitive Processes and Appetite
Medication studyAges 18–55United KingdomEating disorders
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- BirminghamSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 1, 2019
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 22
- Sponsor
- University of Birmingham
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT04181957
- Official title
Show the full official title
The Effects of Lisdexamfetamine Dimesylate on Cognitive, Metabolic, and Reward Processes in Individuals With Binge-eating Symptoms
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Birmingham, a university.
Does this study involve medication?
Yes. The study involves medication, including Placebo oral tablet and Lisdexamfetamine Dimesylate.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as terminated.
